Eurand Reports Recent Developments and Second Quarter 2008 Financial Results
August 07, 2008 07:00 ET
|
Eurand N.V.
Highlights:
* Received approvable letter for New Drug Application (NDA) for
EUR-1008 (Zentase(r))
* Achieved successful FDA pre-approval inspection of Milan
manufacturing facility...
Eurand to Receive $35 Million Payment in Litigation Settlement
August 06, 2008 08:55 ET
|
Eurand N.V.
DAYTON, Ohio, Aug. 6, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) today announced that Eurand Inc. and UCB, Inc. have settled long-running litigation concerning a 1999 development, license and...
Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant
August 01, 2008 09:45 ET
|
Eurand N.V.
PHILADELPHIA, Pa., Aug. 1, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Announces Conference Call On Second Quarter 2008 Financial Results
July 18, 2008 08:00 ET
|
Eurand N.V.
AMSTERDAM, The Netherlands, July 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Industrial Award Honors Achievement in Drug Delivery Research
July 16, 2008 16:11 ET
|
Eurand N.V.
MILAN, Italy, July 16, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) and the Controlled Release Society (CRS) announced today that the 2008 Eurand Industrial Award has been presented to...
Eurand Names Bill Newbould Vice President, Investor Relations
July 10, 2008 08:00 ET
|
Eurand N.V.
PHILADELPHIA, July 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)
June 18, 2008 16:05 ET
|
Eurand N.V.
PHILADELPHIA, June 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand to Be Issued U.S. Patent for Amrix(r)
June 03, 2008 09:00 ET
|
Eurand N.V.
DAYTON, Ohio, June 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand to Present At UBS Global Specialty and Generic Pharmaceuticals Conference
May 20, 2008 08:00 ET
|
Eurand N.V.
AMSTERDAM, May 20, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical...
Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008
May 15, 2008 16:00 ET
|
Eurand N.V.
AMSTERDAM, The Netherlands, May 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...